About News News Subscribe Economics Health Policy Social Psychology Leadership Social Entrepreneurship Facet Area of Focus - News Ian H. Solomon Craig Volden Brian N. Williams Christine Mahoney Benjamin Castleman Kirsten Gelsdorf Gerald Warburg Gabrielle Adams Philip Potter Daphna Bassok Jay Shimshack Lucy Bassett John Holbein Andrew S. Pennock David Leblang Allan Stam Raymond C. Scheppach Sarah Turner Sophie Trawalter Timothy L. Davis Bala Mulloth Sebastian Tello Trillo Eileen Chou Jeanine Braithwaite Jennifer Lawless Jill Rockwell Todd S. Sechser Alexander Bick James H. Wyckoff Paul S. Martin Peter Johannessen Steve Hiss Daniel W. Player Gerard Robinson Laura Toscano Michael D. Williams Noah Myung William Shobe Brooke Lehmann Harry Harding James R. Detert Jazmin Brown-Iannuzzi Jeff Chidester Kyle S. H. Dobson Larry Terry Margaret Foster Riley Molly Lipscomb Abigail Scholer Adam Leive Allison Atteberry Andrew Simon Brad Carson Derek Wu Frederick P. Hitz Galen Fountain Gerald Higginbotham Isaac Mbiti Michele Claibourn Sally Hudson Tim Layton Xiao Wang Adam Roux Amanda Crombie Andy Ortiz Ashley Jardina Brendan J. Boler Brooke Ray Charles J. Rush Charles J. Rush Diane Biesecker George Foresman Jieun Pai Justin H. Kirkland Kimberly Jenkins Robinson Melissa Thomas-Hunt Pam Cipriano Paul Becker Tim Layton (-) Christopher J. Ruhm (-) Benjamin Converse Facet People - News School Engineering Social Innovation @ UVA Facet UVA Partner - News Research and Commentary Accolades Faculty In Action Facet News Type - News Apr 07, 2021 Why Our Brains Miss Opportunities to Improve through Subtraction Social Psychology Leadership In a new paper featured on the cover of Nature, Batten’s Gabrielle Adams, Benjamin Converse and co-authors explain why people systematically overlook subtractive improvements. Learn more Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY Pagination Previous page ‹ Previous Page 1 Current page 2 Stay Up To Date with the Latest Batten News and Events Subscribe
Apr 07, 2021 Why Our Brains Miss Opportunities to Improve through Subtraction Social Psychology Leadership In a new paper featured on the cover of Nature, Batten’s Gabrielle Adams, Benjamin Converse and co-authors explain why people systematically overlook subtractive improvements. Learn more
Apr 09, 2020 How Might the COVID-19 Recession Affect Your Health? An Economist Explains. Economics Health Policy Recessions may be good for overall physical health, but this one could be different. Batten professor Chris Ruhm presented an online talk Wednesday offering an economist’s view of the overall health effects of the COVID-19 recession. His talk was the school’s third installment of its expert chat series about COVID-19. Learn more
Nov 21, 2019 New Research: Non-Opioid Drug Death Rates Are Also on the Rise Economics The number of Americans dying from drug overdoses has risen rapidly in the last decade, with opioids viewed as the primary culprit. However, recent research suggests that opioids are not the only drug involved. According to Batten professor of economics, Christopher J. Ruhm, half of the overdose deaths have involved polydrug use and deaths involving nonopioid drugs are rising almost as fast as those involving opioids. READ IN UVA TODAY